02.07.2022 | Tracker

Top 50 Pharma Tracker: HCPs share mixed opinions on COVID-19 vaccines and treatment data

By Francesca Gan and Chawanzi Chintu

Discover what healthcare professionals (HCPs) think about pharmaceutical products and their manufacturers, as it happens, through CREATION.co’s tracking updates. How are HCPs responding to drug launch news? How are HCPs talking about or engaging with the Top 50 pharma companies on social media? Each week, CREATION.co’s tracking updates bring you the latest insights from the conversation of HCPs across the globe discussing these topics and more.

The Top 50 Pharmaceutical Companies mentioned by HCPs on Twitter

June RankMay RankCompany
Name
Total
Mentions
Account
Mentions
Account
Retweets
11Pfizer8,19384649
2N/AModerna5,1772240
32Johnson & Johnson1,09856359
43AstraZeneca74026832
55GSK50515537
68Novartis50331075
77Roche42020448
813Novo Nordisk39734838
94Abbott3853265
1026Otsuka37920
1110Sanofi29618936
1216Biogen2811875
1311Bayer280869
149AbbVie2221705
1514Merck & Co20914527
1612Lilly1991427
1715Takeda16915710
1817BMS1471144
1921Amgen14612010
2018Boehringer Ingelheim1448714
216Gilead Sciences128816
2222Fresenius1257710
2338Vertex70700
2420Regeneron70512
2519Teva66598
2623Daiichi Sankyo65235
27N/AStada6130
2836Astellas61440
2925UCB535113
30N/AOrganon4810
3127Merck KGaA36358
3231Bausch3620
3328Ipsen28142
3424Servier26143
3539Menarini23173
3635CSL222111
3732Eisai22124
38N/AJazz Pharmaceuticals1820
3937Grifols1600
4033Alexion1351
41N/AViatris910
42N/ACSPC500
4341Sun310
4450Jiangsu Hengrui100
44N/AKyowa Kirin100
4450Aurobindo100
5050Endo000
5050Sino000
5050Shanghai000
5050Sumitomo Dainippon000

The latest insights from HCPs mentioning the Top 50 Pharmaceutical Companies

The five pharmaceutical companies that were mentioned the most by HCPs on Twitter during June 2022 were Pfizer, Moderna, Johnson & Johnson, AstraZeneca and GSK.

A graph showing HCP mentions of pharmaceutical companies on Twitter

CREATION.co identified an increase in mentions of pharmaceutical companies by HCPs this month compared to last month, increasing from 16,943 to 17,585 posts. Following a new list of Top 50 Companies posted by Pharmaceutical Executive Moderna made its first appearance in the top five most mentioned pharmaceutical companies by HCPs online. Other companies that are now being analysed in CREATION.co’s Top 50 Pharma Tracker include, Stada, Organon, Jazz Pharmaceuticals, Viatris, CSPC, and Kyowa Kirin.

Unsurprisingly, Moderna’s jump from outside the Top 50 to the second most mentioned pharmaceutical company in June 2022 was largely because of conversation surrounding Moderna’s COVID-19 vaccine, as evidenced by Oncologist Vinay Prasad’s post which specifically mentioned the Moderna vaccine while expressing his opinion on vaccine safety.

The top shared links by HCPs discussed multiple issues surrounding COVID-19 vaccines:

  1. An FDA News Release about the authorisation of the Moderna COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine to include use in children down to 6 months of age. 
  2. A Report from Pfizer showing additional data on PAXLOVID™ supporting upcoming new drug application submission to U.S. FDA.
  3. An FDA Briefing Document submitted for amendment for the use of Pfizer’s COVID-19 vaccine in children under 5.

A graph showing HCP discussing Paxlovid and COVID-19 vaccine approvalsThe prominent driver of conversation in June 2022 came from HCP discussions following the release of EPIC-SR trial results which investigated the efficacy of PAXLOVID™, Pfizer’s anti-viral drug to treat COVID-19 and the FDA’s approval of Pfizer and Moderna COVID-19 vaccines for young children. Infectious disease specialist, David Boulware felt there was a lack of efficacy data for PAXLOVID™, highlighting that there was no proven benefit shown in the trial.

Prominent HCP Dr Eric Ding, alongside other HCPs, shared the news of the unanimous vote by the FDA to recommend the Pfizer and Moderna vaccines for children under five years old. Dr Ding called the news ‘momentous’, showing a positive sentiment towards the outcome of the vote.

CREATION.co continues to analyse online HCP conversation on a variety of topics including virtual congress, healthcare changes since the pandemic, product development and therapy area specific insights.

To stay up to date, you can sign up to CREATION.co’s monthly eJournal.

Methodology notes:

  • In June 2022, CREATION Pinpoint® identified 17,585 healthcare professional (HCP) authored tweets from 6,844 individual HCPs mentioning a Top 50 Pharmaceutical company (according to revenue). 
  • Data for this research was analysed from the online Twitter conversations of HCPs in all languages mentioning a Top 50 Pharmaceutical company between 01 June and 30 June 2022.
  • Unless otherwise specified, mentions of a company are not limited to its Twitter account(s).
  • In some cases, a tweet may mention more than one company account (e.g. @abbottnews and @abbottglobal) – this only counts as one Company Mention and Account Mention.
  • Johnson & Johnson was included as a whole, encompassing its pharmaceutical subsidiary, Janssen. In June 170 of these posts mentioned Janssen.

View the latest and archived tracker here

View all articles >

Meet the Authors

Francesca Gan

Suggested next


09.02.2022 | Article

Product Launch Tracker: HCPs celebrate new treatments for metastatic melanoma and non-small cell lung cancer

HCPs also shared the news of approvals of treatments for NSCLC

By Paul Cranston and Tomi Shobande

UK HCPs protect peers and patients by responding to misinformation

24.04.2020 | Article

UK HCPs protect peers and patients by responding to misinformation

UK HCPs protect peers and patients by responding to misinformation

By Laura Marsh

View all articles >